Yazılar

Oracle Pauses After AI-Fueled Surge Toward $1 Trillion Valuation

/in /tarafından

Oracle shares fell 4% on Thursday, cooling off after a record-breaking 35.9% rally the previous day that had pushed the company’s market capitalization to $933 billion, edging it closer to the trillion-dollar elite. If losses hold, Oracle’s valuation will settle near $894 billion.

Ellison’s Billionaire Climb

The surge has also boosted co-founder Larry Ellison’s fortune to $371.7 billion, putting him within striking distance of Elon Musk ($441.2 billion) for the title of world’s richest person, according to Forbes.

What Fueled the Rally

Oracle’s rise has been powered by multi-billion-dollar AI cloud deals as companies race to secure massive computing power to lead in the AI arms race.

  • On Tuesday, Oracle reported its order backlog was on track to hit $500 billion.

  • The Wall Street Journal revealed OpenAI signed a $300 billion cloud deal with Oracle, one of the largest in history.

Market View

Analysts see the pullback as a breather.

  • Dennis Dick, chief strategist at Stock Trader Network: “A bit of buyer exhaustion here. I think the ‘buy the dip’ crowd is likely to re-emerge. The guidance was so incredible, hard to think that this story is over.”

Oracle’s stock has nearly doubled in 2025, making it one of the top S&P 500 performers, outpacing even the Magnificent Seven tech giants.

Valuation Check

  • Stock price: $314.45

  • Median price target: $342 (approx. +9% upside, LSEG data)

  • Forward P/E ratio: 45.3 vs. Amazon (31.3) and Microsoft (31).

Oracle’s premium valuation reflects investors’ conviction that its AI-powered cloud expansion will continue to drive outsized growth, even as short-term pullbacks test market momentum.

Neuralink Expands Human Trials, 12 People Now Using Brain Implants

/in /tarafından

Elon Musk’s Neuralink announced Tuesday that 12 people worldwide have received its brain implants, marking steady progress in its clinical rollout.

Key Details

  • Patient Numbers: Up from 7 in June, when partner Barrow Neurological Institute confirmed its involvement.

  • Usage Stats: Collectively, patients have logged 2,000 days of implant use and over 15,000 hours of activity, using the device to control both digital and physical tools through thought.

  • Trials Abroad: A new clinical study will launch in the UK, partnering with University College London Hospitals and Newcastle Hospitals.

  • Funding: Neuralink raised $650 million in June to support expansion.

Background

  • Neuralink began human trials in 2024 after overcoming U.S. FDA safety objections that initially blocked approval in 2022.

  • The company’s implants are aimed at restoring movement and communication for people with severe paralysis, representing a major step in brain-computer interface (BCI) technology.

Outlook

  • The trials will help Neuralink test long-term safety, reliability, and potential new medical applications.

  • If successful, the technology could pave the way for broader use cases — from medical rehabilitation to advanced human-computer interaction.

Tesla’s $8.5 Trillion Dream: Musk’s Pay Package Tied to Robots, Robotaxis, and Investor Faith

/in /tarafından

Tesla’s board has tied Elon Musk’s new trillion-dollar pay package to an extraordinary target: growing the company’s market value to $8.5 trillion over the next decade — a figure that would eclipse today’s giants Microsoft and Nvidia combined.

The Road to $8.5 Trillion

  • Robotaxis: Tesla aims to deploy 1 million autonomous taxis, building a network that could dwarf Uber’s business. ARK Invest forecasts up to $951 billion in annual revenue from ride-hailing by 2029, with Tesla taking a higher cut of fares than rivals.

  • Optimus humanoid robots: Musk says robots could represent 80% of Tesla’s value. To hit profit targets, Tesla might need to sell 100 million robots annually, priced around $25,000 each, generating hundreds of billions in EBITDA.

  • EVs & energy: Tesla’s auto and energy units would still contribute, but analysts agree the bulk of upside must come from next-gen products.

Investor Math

  • Tesla trades at about 75x EBITDA, far higher than most automakers.

  • At that multiple, Tesla would need $113 billion EBITDA for $8.5T valuation — below the $400 billion EBITDA goal in Musk’s package.

  • Current EBITDA: $13 billion (LSEG).

Risks & Reality Check

  • Operational hurdles: Vehicle sales have declined, raising near-term challenges.

  • Market skepticism: Morgan Stanley called Tesla’s $400B EBITDA target “materially more aggressive” than its forecasts, requiring massive contributions from robots and AI markets that barely exist today.

  • Regulatory & technical roadblocks: Scaling robotaxis and humanoid robots will demand breakthroughs in autonomy, safety, and manufacturing.

Why Investors Still Believe

  • Narrative power: Tesla is valued as a growth story, not an automaker.

  • Long-term optionality: Robotaxis and robots represent potential trillion-dollar markets.

  • Alignment: Tying Musk’s pay to performance reassures some investors that bold bets are necessary to reverse slowing growth.

As Will Rhind of GraniteShares put it: “There are big operational hurdles Tesla does need to accomplish… so why not tie the CEO’s compensation to reversing some of those trends?”